Garry Nicholson
Fortune : - $ au 31/05/2026
Fortune : - $ au 31/05/2026
Garry Allen Nicholson currently works at Abdera Therapeutics, Inc., as Chairman, Avenzo Therapeutics, Inc., as Director, and TScan Therapeutics, Inc., as Independent Director from 2024.
Mr. Nicholson also formerly worked at XTuit Pharmaceuticals, Inc., as President, Chief Executive Officer & Director from 2015 to 2016, Day One Biopharmaceuticals, Inc., as Chairman from 2022 to 2026, G1 Therapeutics, Inc., as Chairman from 2019 to 2024, Five Prime Therapeutics, Inc., as Independent Director from 2017 to 2021, Tesaro, Inc., as Director, Personal Genome Diagnostics, Inc., as Independent Director, Turning Point Therapeutics, Inc., as Independent Director from 2021 to 2022, SQZ Biotechnologies Co., as Director, The Pfizer Foundation, Inc., as Director, NextCure, Inc., as Independent Director from 2020 to 2023, Tmunity Therapeutics, Inc., as Director, and Pfizer Inc., as President-Pfizer Oncology from 2008 to 2015.
Mr. Nicholson received his undergraduate degree from The University of North Carolina at Chapel Hill and Masters Business Admin degree from the University of South Carolina.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 20/05/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| TSCAN THERAPEUTICS, INC. | Directeur/Membre du Conseil | 14/06/2024 |
Abdera Therapeutics, Inc.
Abdera Therapeutics, Inc. Packaged SoftwareTechnology Services Develops precision radiotherapeutics platform | Président | - |
Avenzo Therapeutics, Inc.
Avenzo Therapeutics, Inc. BiotechnologyHealth Technology Engages in research and development for oncology therapies used in treating of cancer | Directeur/Membre du Conseil | - |
| Sociétés | Poste | Fin |
|---|---|---|
| DAY ONE BIOPHARMACEUTICALS, INC. | Président | 23/04/2026 |
| G1 THERAPEUTICS, INC. | Président | 18/09/2024 |
| NEXTCURE, INC. | Directeur/Membre du Conseil | 15/08/2023 |
| TURG POIN | Président | 24/05/2021 |
| FIVE PRIME THERAPEUTICS, INC. | Directeur/Membre du Conseil | 16/04/2021 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 17 |
|---|---|
Pfizer Inc.
Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Five Prime Therapeutics, Inc.
Five Prime Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops protein therapeutics for cancer and inflammatory diseases | Health Technology |
Tesaro, Inc.
Tesaro, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops drugs for cancer patients | Health Technology |
Personal Genome Diagnostics, Inc.
Personal Genome Diagnostics, Inc. BiotechnologyHealth Technology Provides cancer genome analysis to help researchers identify cancer-related genetic changes | Health Technology |
Turning Point Therapeutics, Inc.
Turning Point Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage structure-based drug design company for discovery and development of precision medicines for cancer and other diseases | Health Technology |
SQZ Biotechnologies Co.
SQZ Biotechnologies Co. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops cell therapies for patients with cancer, infectious diseases and serious conditions | Health Technology |
The University of North Carolina at Chapel Hill
The University of North Carolina at Chapel Hill Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of South Carolina
University of South Carolina Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Pfizer Foundation, Inc.
The Pfizer Foundation, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as charitable organization, which fund programs that provide public benefit, advance medical care and improve patient outcomes | Commercial Services |
XTuit Pharmaceuticals, Inc.
XTuit Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for the treatment of cancer | Health Technology |
G1 Therapeutics, Inc.
G1 Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for cancer treatment | Health Technology |
Tmunity Therapeutics, Inc.
Tmunity Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company | Commercial Services |
NextCure, Inc.
NextCure, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which discovers and develops novel immuno medicines to treat cancer & immune related diseases | Health Technology |
TScan Therapeutics, Inc.
TScan Therapeutics, Inc. BiotechnologyHealth Technology Develops T-cell therapies for cancer patients | Health Technology |
Abdera Therapeutics, Inc.
Abdera Therapeutics, Inc. Packaged SoftwareTechnology Services Develops precision radiotherapeutics platform | Technology Services |
Day One Biopharmaceuticals, Inc.
Day One Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biopharmaceutical company which develops and commercializes targeted therapies for cancers | Health Technology |
Avenzo Therapeutics, Inc.
Avenzo Therapeutics, Inc. BiotechnologyHealth Technology Engages in research and development for oncology therapies used in treating of cancer | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national